Analyst Ratings for HCP (HCP)
HCP Rating Summary
HCP Price Target Summary
- Highest: $53.00 (Goldman Sachs)
- Lowest: $36.00 (Baird)
- Average: $45.43
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$45.43 (-17.6%)
Avg. $ Target:
$45.43 (-17.6%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/21/2013 | Goldman Sachs | New Coverage | Neutral (N/A) |
53.00 (N/A) |
48.49 | 55.11 | 13.65% | Details |
| 3/12/2013 | Macquarie | Upgrade | Outperform (Neutral) |
N/A (N/A) |
48.89 | 55.11 | 12.72% | Details |
| 3/1/2013 | BMO Capital | Upgrade | Market Perform (Underperform) |
49.00 (43.00) |
48.88 | 55.11 | 12.75% | Details |
| 2/5/2013 | Barclays | New Coverage | Equalweight (N/A) |
50.00 (N/A) |
46.70 | 55.11 | 18.01% | Details |
| 1/10/2013 | KeyBanc | Upgrade | Hold (Underweight) |
N/A (N/A) |
45.58 | 55.11 | 20.91% | Details |
| 10/10/2012 | RBC Capital | New Coverage | Sector Perform (N/A) |
46.00 (N/A) |
45.43 | 55.11 | 21.31% | Details |
| 2/7/2012 | Stifel Nicolaus | Upgrade | Buy (N/A) |
N/A (N/A) |
41.67 | 55.11 | 32.25% | Details |
| 1/18/2012 | BofA/Merrill Lynch | Downgrade | Underperform (N/A) |
N/A (N/A) |
41.56 | 55.11 | 32.6% | Details |
| 10/6/2011 | Morgan Stanley | New Coverage | Equalweight (N/A) |
38.00 (N/A) |
35.02 | 55.11 | 57.37% | Details |
| 8/18/2011 | Baird | Downgrade | Neutral (N/A) |
36.00 (N/A) |
34.70 | 55.11 | 58.82% | Details |
| 8/9/2011 | Hilliard Lyons | Upgrade | Neutral (N/A) |
N/A (N/A) |
28.77 | 55.11 | 91.55% | Details |
| 3/22/2011 | Sandler O’Neill | Downgrade | Hold (N/A) |
N/A (N/A) |
37.60 | 55.11 | 46.57% | Details |
| 1/21/2011 | Keefe, Bruyette & Woods | New Coverage | Market Perform (N/A) |
N/A (N/A) |
36.13 | 55.11 | 52.53% | Details |
| 11/22/2010 | UBS | Upgrade | Neutral (N/A) |
N/A (N/A) |
32.56 | 55.11 | 69.26% | Details |
| 8/18/2010 | Argus | Upgrade | Buy (N/A) |
N/A (N/A) |
35.20 | 55.11 | 56.56% | Details |
